13F Data
Security · CUSIP 761330AB5

REVANCE THERAPEUTICS INC

NOTE 1.750% 2/1 · institutional ownership from 13F filings
13F holders
5
Shares held
962.4K
Value held
$10.9M
New / sold out
3 / 0
Added / reduced
0 / 0
net +932.4K shares

13F holders by quarter

Q1 2021: 4Q2 2021: 3Q3 2021: 2Q4 2021: 2Q1 2022: 2Q2 2022: 2Q3 2022: 5Q4 2022: 2Q1 2023: 5Q2 2023: 5Q3 2023: 4Q4 2023: 3Q1 2024: 2Q2 2024: 2Q3 2024: 2Q4 2024: 2Q1 2025: 0
Q1 2021Q1 2025

Net shares bought by existing holders

Q1 2021: 17.3MQ2 2021: 4.1MQ3 2021: -16.1MQ4 2021: -5.2MQ1 2022: 0Q2 2022: 0Q3 2022: 932.4KQ4 2022: -862.4KQ1 2023: 180.3KQ2 2023: 58.4KQ3 2023: 6.1MQ4 2023: -208.0KQ1 2024: -15.0KQ2 2024: 0Q3 2024: -130.0KQ4 2024: -150.0KQ1 2025: -2.8M
Q1 2021Q1 2025

Top holders · Q3 2022

ManagerSharesValue% of portfolio
BNP PARIBAS ARBITRAGE, SNC257,363$6.9M0.00%
WEDBUSH SECURITIES INC30,000$3.3M0.18%
JANE STREET GROUP, LLC375,000$394.0K0.00%
Bank of New York Mellon Corp300,000$314.0K0.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC.0$00.00%

Biggest buyers

ManagerChangeShares changeChange %
JANE STREET GROUP, LLCNew+375,000–
Bank of New York Mellon CorpNew+300,000–
BNP PARIBAS ARBITRAGE, SNCNew+257,363–

Biggest sellers

Nothing to show.